Cargando…
105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy
BACKGROUND: Recently, we demonstrated in an experimental mouse study that mucosal M-cell targeting with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolide) (PLGA) microspheres represents a promising oral treatment approach in IgE mediated allergy. Due to its structural similarities w...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512756/ http://dx.doi.org/10.1097/01.WOX.0000411850.99675.15 |
_version_ | 1782251794585354240 |
---|---|
author | Diesner, Susanne C. Schultz, Cornelia Wang, Xueyan Ratzinger, Gerda Starkl, Philipp Assmann, Vera Kreiner, Kristina Roth-Walter, Franziska Pali-Schöll, Isabella Jensen-Jarolim, Erika Gabor, Franz Untersmayr, Eva |
author_facet | Diesner, Susanne C. Schultz, Cornelia Wang, Xueyan Ratzinger, Gerda Starkl, Philipp Assmann, Vera Kreiner, Kristina Roth-Walter, Franziska Pali-Schöll, Isabella Jensen-Jarolim, Erika Gabor, Franz Untersmayr, Eva |
author_sort | Diesner, Susanne C. |
collection | PubMed |
description | BACKGROUND: Recently, we demonstrated in an experimental mouse study that mucosal M-cell targeting with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolide) (PLGA) microspheres represents a promising oral treatment approach in IgE mediated allergy. Due to its structural similarities with AAL we aimed to assess Neuraminidase (NA) from Vibrio cholerae as a novel M-cell specific targeters and compared its properties to AAL and wheat germ agglutinin (WGA) representing 2 plant lectins, which target either M-cells or epithelial cells, respectively. METHODS: The resistance against gastric digestion of NA, AAL and WGA was analyzed in simulated gastric fluid (SGF) experiments. Intestinal epithelial binding was determined using the colon carcinoma cell line Caco2, which represents a well established model for the human intestinal epithelium. Binding specificity was evaluated by inhibition experiments by incubating Caco2 cells with Biotin-labeled NA, AAL or WGA, after preincubation with a-L fucose, monoganglioside (GM1) or N,N′,N″-triacetyl-chitotriose (TCT). The stimulatory effects of the targeting substances on the intestinal microenvironment were investigated by cytokine read-out experiments in real-time PCR. Further, the transeptihelial uptake of NA-, AAL- or WGA-functionalized fluospheres was evaluated in a human M-cell co-culture model. RESULTS: All 3 targeters were stable up to 180 minutes in SGF, indicating their suitability for oral application. The binding partners were a-L fucose for AAL and TCT for WGA, whereas NA interacts with intestinal epithelial cells via a-L fucose and additionally GM1. NA skewed the cytokine production by inducing a 2-fold increase of the Th1 cytokine IFNg after 60 minutes, whereas AAL decreased the overall cytokine expression. In a human M-cell co-culture model, a higher transepithelial transport rate of fluospheres coated with NA and AAL was observed as compared to WGA and plain particles. CONCLUSIONS: NA specifically targets M-cells via a-L fucose and additionally GM1 and, thus, increases the transepithelial transport of NA coated particles. Due to the immunomodulatory capacity on intestinal epithelial cells, NA functionalized microspheres may represent a promising M-cell specific targeting approach for oral immunotherapy. |
format | Online Article Text |
id | pubmed-3512756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | World Allergy Organization Journal |
record_format | MEDLINE/PubMed |
spelling | pubmed-35127562012-12-21 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy Diesner, Susanne C. Schultz, Cornelia Wang, Xueyan Ratzinger, Gerda Starkl, Philipp Assmann, Vera Kreiner, Kristina Roth-Walter, Franziska Pali-Schöll, Isabella Jensen-Jarolim, Erika Gabor, Franz Untersmayr, Eva World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Recently, we demonstrated in an experimental mouse study that mucosal M-cell targeting with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolide) (PLGA) microspheres represents a promising oral treatment approach in IgE mediated allergy. Due to its structural similarities with AAL we aimed to assess Neuraminidase (NA) from Vibrio cholerae as a novel M-cell specific targeters and compared its properties to AAL and wheat germ agglutinin (WGA) representing 2 plant lectins, which target either M-cells or epithelial cells, respectively. METHODS: The resistance against gastric digestion of NA, AAL and WGA was analyzed in simulated gastric fluid (SGF) experiments. Intestinal epithelial binding was determined using the colon carcinoma cell line Caco2, which represents a well established model for the human intestinal epithelium. Binding specificity was evaluated by inhibition experiments by incubating Caco2 cells with Biotin-labeled NA, AAL or WGA, after preincubation with a-L fucose, monoganglioside (GM1) or N,N′,N″-triacetyl-chitotriose (TCT). The stimulatory effects of the targeting substances on the intestinal microenvironment were investigated by cytokine read-out experiments in real-time PCR. Further, the transeptihelial uptake of NA-, AAL- or WGA-functionalized fluospheres was evaluated in a human M-cell co-culture model. RESULTS: All 3 targeters were stable up to 180 minutes in SGF, indicating their suitability for oral application. The binding partners were a-L fucose for AAL and TCT for WGA, whereas NA interacts with intestinal epithelial cells via a-L fucose and additionally GM1. NA skewed the cytokine production by inducing a 2-fold increase of the Th1 cytokine IFNg after 60 minutes, whereas AAL decreased the overall cytokine expression. In a human M-cell co-culture model, a higher transepithelial transport rate of fluospheres coated with NA and AAL was observed as compared to WGA and plain particles. CONCLUSIONS: NA specifically targets M-cells via a-L fucose and additionally GM1 and, thus, increases the transepithelial transport of NA coated particles. Due to the immunomodulatory capacity on intestinal epithelial cells, NA functionalized microspheres may represent a promising M-cell specific targeting approach for oral immunotherapy. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512756/ http://dx.doi.org/10.1097/01.WOX.0000411850.99675.15 Text en Copyright © 2012 by World Allergy Organization |
spellingShingle | Abstracts of the XXII World Allergy Congress Diesner, Susanne C. Schultz, Cornelia Wang, Xueyan Ratzinger, Gerda Starkl, Philipp Assmann, Vera Kreiner, Kristina Roth-Walter, Franziska Pali-Schöll, Isabella Jensen-Jarolim, Erika Gabor, Franz Untersmayr, Eva 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy |
title | 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy |
title_full | 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy |
title_fullStr | 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy |
title_full_unstemmed | 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy |
title_short | 105 M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy |
title_sort | 105 m-cell targeting by neuraminidase functionalized microparticles for future application in oral immunotherapy |
topic | Abstracts of the XXII World Allergy Congress |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512756/ http://dx.doi.org/10.1097/01.WOX.0000411850.99675.15 |
work_keys_str_mv | AT diesnersusannec 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT schultzcornelia 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT wangxueyan 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT ratzingergerda 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT starklphilipp 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT assmannvera 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT kreinerkristina 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT rothwalterfranziska 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT palischollisabella 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT jensenjarolimerika 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT gaborfranz 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy AT untersmayreva 105mcelltargetingbyneuraminidasefunctionalizedmicroparticlesforfutureapplicationinoralimmunotherapy |